MedicarePartD.guide

A non-government resource built from CMS public data

TELMISARTAN AND AMLODIPINE 80/5 mg Tablet

Coverage in Nevada (CMS PDP Region 29).

3 of 10 stand-alone Part D plans in Nevada cover this drug on tier 1–4.

Lowest 30-day cost $0.00 at a preferred pharmacy. 2 of 3 plans apply a prior authorization, step therapy or quantity limit.

75 Medicare Advantage plans in NV do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. NV: 75 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Wellcare Value Script (PDP)$2.70/mo premium · $615.00 deductible1Preferred Generic$0.00$0.00$1.1535$3.463 units
  • Quantity limit 3 per 30 days
HealthSpring Extra Rx (PDP)$52.60/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$3.5899—None
SilverScript Choice (PDP)$97.40/mo premium · $615.00 deductible4Non-Preferred Drug33%33%$4.1762$12.533 units
  • Quantity limit 3 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →